Back to Search
JAMES ABBRUZZESE, M.D.
M.D.
Medical Oncology Physician
NPI: 1134233224Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.
PMID 19435822·Mol Cancer Res·2009
8-other
The convergence of cancer prevention and therapy in early-phase clinical drug development.
PMID 15488755·Cancer Cell·2004
6-review
Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality.
PMID 12577227·Semin Oncol·2002
6-review
New applications of gemcitabine and future directions in the management of pancreatic cancer.
PMID 12209675·Cancer·2002
6-review
Highlights of the 2008 San Antonio Breast Cancer Symposium.
PMID 19274039·Clin Adv Hematol Oncol·2009
8-other
Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
PMID 19549972·JAMA·2009
8-other
Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.
PMID 19276344·Cancer Res·2009
8-other
Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.
PMID 19141650·Cancer Res·2009
8-other
Antidiabetic therapies affect risk of pancreatic cancer.
PMID 19375425·Gastroenterology·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1134233224
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile